Severity of Anemia During Pregnancy and Adverse Maternal and Fetal Outcomes
- PMID: 35113162
- PMCID: PMC8814908
- DOI: 10.1001/jamanetworkopen.2021.47046
Severity of Anemia During Pregnancy and Adverse Maternal and Fetal Outcomes
Abstract
Importance: Anemia is the most widespread nutritional deficiency among pregnant females in the world. Despite numerous studies on anemia, evidence is limited about the association of severity of anemia with maternal and fetal health.
Objective: To investigate the association between severity of anemia during pregnancy and risk of maternal and fetal adverse outcomes.
Design, setting, and participants: This retrospective cohort study used data from China's Hospital Quality Monitoring System from January 1, 2016, to December 31, 2019, for pregnant females aged 15 to 49 years with birth outcomes reported at 1508 hospitals with maternity services in mainland China.
Exposures: Anemia of varying severity during pregnancy was identified from daily standardized electronic inpatient discharge records using corresponding codes of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. Mild anemia was defined as a hemoglobin concentration of 100 to 109 g/L (to convert g/L to g/dL, divide by 10.0); moderate anemia, as 70 to 99 g/L; and severe anemia, as less than 70 g/L.
Main outcomes and measures: The main outcomes included 6 maternal outcomes (placental abruption, preterm birth, severe postpartum hemorrhage, shock, admission to the intensive care unit [ICU], and maternal mortality) and 3 neonatal outcomes (fetal growth restriction, malformation, and stillbirth). Multivariable logistic regression models were used to estimate the odds ratios (ORs) and 95% CIs of these outcomes among pregnant females with varying severity of anemia.
Results: Among 18 948 443 pregnant females aged 15 to 49 years (mean [SD] age, 29.42 [4.87] years), 17.78% were diagnosed with anemia during pregnancy, including 9.04% with mild anemia, 2.62% with moderate anemia, 0.21% with severe anemia, and 5.90% with anemia of unknown severity. Compared with no anemia, anemia severity during pregnancy was associated with increased risks of placental abruption (mild: adjusted OR [aOR], 1.36 [95% CI, 1.34-1.38]; moderate: aOR, 1.98 [95% CI, 1.93-2.02]; severe: aOR, 3.35 [95% CI, 3.17-3.54]), preterm birth (mild: aOR, 1.08 [95% CI, 1.07-1.08]; moderate: aOR, 1.18 [95% CI, 1.17-1.19]; severe: aOR, 1.36 [95% CI, 1.32-1.41]), severe postpartum hemorrhage (mild: aOR, 1.45 [95% CI, 1.43-1.47]; moderate: aOR, 3.53 [95% CI, 3.47-3.60]; severe: 15.65 [95% CI, 15.10-16.22]), and fetal malformation (mild: aOR, 1.15 [95% CI, 1.14-1.17]; moderate: aOR, 1.19 [95% CI, 1.16-1.21]; severe: aOR, 1.62 [95% CI, 1.52-1.73]). Compared with no anemia, moderate or severe anemia were associated with increased risks of maternal shock (moderate: aOR, 1.50 [95% CI, 1.41-1.60]; severe: aOR, 14.98 [95% CI, 13.91-16.13]), ICU admission (moderate: aOR, 1.08 [95% CI, 1.01-1.16]; severe: aOR, 2.88 [95% CI, 2.55-3.25]), maternal death (moderate: aOR, 0.45 [95% CI, 0.30-0.65]; severe: aOR, 1.56 [95% CI, 0.97-2.48], fetal growth restriction (moderate: aOR, 0.80 [95% CI, 0.78-0.82]; severe: aOR, 1.08 [95% CI, 1.00-1.17]), and stillbirth (moderate: aOR,0.79 [95% CI, 0.76-0.81]; severe: aOR, 1.86 [95% CI, 1.75-1.98]), and mild anemia was associated with decreased risks (maternal shock: aOR, 0.67 [95% CI, 0.63-0.71]; ICU admission: aOR, 0.80 [95% CI, 0.76-0.84]; maternal death: aOR, 0.37 [95% CI, 0.29-0.49]; fetal growth restriction: aOR, 0.79 [95% CI, 0.77-0.80]; stillbirth: aOR, 0.59 [95% CI, 0.58-0.61]) after adjusting for sociodemographic characteristics and other complications during pregnancy.
Conclusions and relevance: The findings suggest that anemia during pregnancy is associated with maternal and fetal health outcomes and that mild anemia is associated with improved maternal and fetal survival and fetal growth. Further work is needed to validate the concentration of hemoglobin at which optimal maternal and fetal health are achieved.
Conflict of interest statement
Figures
Similar articles
-
Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy.Obstet Gynecol. 2019 Dec;134(6):1234-1244. doi: 10.1097/AOG.0000000000003557. Obstet Gynecol. 2019. PMID: 31764734 Free PMC article.
-
Maternal and Neonatal Outcomes of Iron Deficiency Anemia: A Retrospective Cohort Study.Cureus. 2023 Dec 30;15(12):e51365. doi: 10.7759/cureus.51365. eCollection 2023 Dec. Cureus. 2023. PMID: 38292987 Free PMC article.
-
The association of maternal anaemia with adverse maternal and foetal outcomes in Somali women: a prospective study.BMC Womens Health. 2023 Apr 25;23(1):193. doi: 10.1186/s12905-023-02382-4. BMC Womens Health. 2023. PMID: 37098536 Free PMC article.
-
Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy.Cochrane Database Syst Rev. 2019 Sep 16;9(9):CD011192. doi: 10.1002/14651858.CD011192.pub3. Cochrane Database Syst Rev. 2019. PMID: 31523806 Free PMC article.
-
[Review by expert group in the diagnosis and treatment of anemia in pregnant women. Federación Mexicana de Colegios de Obstetricia y Ginecología].Ginecol Obstet Mex. 2012 Sep;80(9):563-80. Ginecol Obstet Mex. 2012. PMID: 23243836 Spanish.
Cited by
-
A district-level geospatial analysis of anaemia prevalence among rural men in India, 2019-21.Int J Equity Health. 2024 Jan 19;23(1):9. doi: 10.1186/s12939-023-02089-w. Int J Equity Health. 2024. PMID: 38243230 Free PMC article.
-
The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial.Blood Adv. 2024 Nov 12;8(21):5683-5694. doi: 10.1182/bloodadvances.2024013408. Blood Adv. 2024. PMID: 39208353 Free PMC article. Clinical Trial.
-
Iron Deficiency Anaemia in Pregnancy: A Narrative Review from a Clinical Perspective.Diagnostics (Basel). 2024 Oct 17;14(20):2306. doi: 10.3390/diagnostics14202306. Diagnostics (Basel). 2024. PMID: 39451629 Free PMC article. Review.
-
Iron overload in anaemia with underlying haemoglobin constant spring in an antenatal mother in primary care.BMJ Case Rep. 2024 Feb 17;17(2):e258526. doi: 10.1136/bcr-2023-258526. BMJ Case Rep. 2024. PMID: 38367998
-
Prevalence of and risk factors for iron deficiency among pregnant women with moderate or severe anaemia in Nigeria: a cross-sectional study.BMC Pregnancy Childbirth. 2024 Jan 5;24(1):39. doi: 10.1186/s12884-023-06169-1. BMC Pregnancy Childbirth. 2024. PMID: 38182997 Free PMC article.
References
-
- World Health Organization . Global anemia reduction efforts among women of reproductive age: impact, achievement of targets and the way forward for optimizing efforts. World Health Organization; 2020. Accessed December 22, 2020. https://www.who.int/publications/i/item/9789240012202
-
- World Health Organization . Global nutrition monitoring framework: operational guidance for tracking progress in meeting targets for 2025. World Health Organization; 2017. Accessed December 15, 2020. https://www.who.int/publications/i/item/9789241513609
-
- World Health Organization . Prevalence of anemia in pregnant women. Geneva, Switzerland: World Health Organization; 2020. Accessed December 9, 2020. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/preva...
-
- World Health Organization . Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization; 2011. Accessed December 19, 2020. https://www.who.int/vmnis/indicators/haemoglobin.pdf
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical